Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries
Background Substandard and falsified medicines in Africa are a major public health concern. Access to quality medical products in African countries is governed in large part by two major entities at the national level: the regulatory authority and the procurement agency. The importance of national r...
Saved in:
| Main Authors: | Jillian C. Kohler, Mariangela Castro-Arteaga, Saher Panjwani, David Mukanga, Murray M. Lumpkin, Bonface Fundafunda, Anthony B. Kapeta, Chimwemwe Chamdimba, Anna S. Y. Wong, Kristin N. Harper, Charles Preston |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2024.2436898 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Do transparency and accountability enhance regulatory compliance in public procurement? Evidence from Tanzania
by: Goodluck G. Ntangeki, et al.
Published: (2023-12-01) -
Combating substandard and falsified medicines in China: policy barriers and the role of pharmaceutical track-and-trace systems
by: Tangsiwei Xin
Published: (2025-12-01) -
Procurement skills and procurement performance in public organizations: The mediating role of procurement planning
by: Ismail Abdi Changalima, et al.
Published: (2023-12-01) -
Applying real-world data to justify requirements to purchased drugs in public procurement
by: M. A. Borzova
Published: (2021-08-01) -
Assessing the Design Coherence of a Social Procurement Regulatory System: Victoria’s Experiment
by: David Goodwin, et al.
Published: (2025-07-01)